The Gross Margin of Enorama Pharma AB (ERMA.ST) is 23.48%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 23.48% |
| 2023-12-31 | -287.26% |
| 2022-12-31 | -9.00% |
| 2021-12-31 | 35.31% |
| 2020-12-31 | 128.52% |
| 2019-12-31 | 137.11% |
| 2018-12-31 | 227.92% |
| 2017-12-31 | 337.37% |